Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$106.37 - $130.68 $540,572 - $664,115
-5,082 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $36,635 - $43,699
-356 Reduced 6.55%
5,082 $575,000
Q2 2021

Aug 06, 2021

BUY
$83.84 - $104.76 $169,105 - $211,300
2,017 Added 58.96%
5,438 $563,000
Q1 2021

May 10, 2021

BUY
$78.68 - $90.67 $269,164 - $310,182
3,421 New
3,421 $286,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Thrive Capital Management, LLC Portfolio

Follow Thrive Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrive Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thrive Capital Management, LLC with notifications on news.